Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shengmai Liquid for Long COVID Fatigue: a Randomized Placebo-controlled Trial.

NCT06980636 is registered in ClinicalTrials.gov with Beijing University of Chinese Medicine as lead sponsor.

NCT NCT06980636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06980636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shengmai Liquid for Long COVID Fatigue: a Randomized Placebo-controlled Trial.
Lead sponsor
Beijing University of Chinese Medicine
Phase
Phase 4
Overall status
Recruiting
Start date
December 1, 2025
Completion date
November 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid fatigue